{
    "title": "Israeli life science firms seek help to follow Teva's lead",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3153351/Israeli-life-science-firms-seek-help-follow-Tevas-lead.html",
    "date": "2015-07-08",
    "keywords": [
        "israel",
        "life",
        "science",
        "government",
        "july",
        "drug",
        "venture",
        "lack",
        "capital",
        "help",
        "gmt",
        "company",
        "industry",
        "biotech",
        "johnson",
        "merck",
        "research",
        "ms",
        "model",
        "health",
        "head",
        "year",
        "technology",
        "nasdaq",
        "way",
        "manufacturing",
        "experience",
        "infrastructure",
        "cohendayag",
        "lead",
        "email",
        "cohentel",
        "aviv",
        "teva",
        "mylan",
        "food",
        "chain",
        "raft",
        "laddernow",
        "boss",
        "future",
        "companys",
        "successisrael",
        "biopharma",
        "firm",
        "tel",
        "stock",
        "exchange",
        "sectorbut",
        "heavyweightsnovartis",
        "rebif",
        "sclerosis",
        "country",
        "wealth",
        "expertise",
        "drain",
        "nation",
        "erez",
        "vigodman",
        "launch",
        "device",
        "drugmaker",
        "fortune",
        "copycat",
        "costlier",
        "sector",
        "today",
        "profit",
        "treatment",
        "problem",
        "claudio",
        "funding",
        "university",
        "level",
        "record",
        "center",
        "percent",
        "rate",
        "growth",
        "startups",
        "pwc",
        "associationalso",
        "tape",
        "dont",
        "development",
        "compugen",
        "ceo",
        "anat",
        "reuterscompugen",
        "cancer",
        "immunotherapy",
        "serono",
        "equipment",
        "addition",
        "contract",
        "complaint",
        "process",
        "regulator",
        "approval",
        "protalix"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}